Muxing Li

995 total citations
25 papers, 744 citations indexed

About

Muxing Li is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Muxing Li has authored 25 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Muxing Li's work include Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Muxing Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Muxing Li collaborates with scholars based in China, Australia and United States. Muxing Li's co-authors include Yi Lv, Jiwen Cheng, Zhengwen Liu, Xu‐Feng Zhang, Wanli Wang, Xuemin Liu, Jian Dong, Ying Zhu, Le Ma and Jianfei Zhang and has published in prestigious journals such as PLoS ONE, IEEE Transactions on Geoscience and Remote Sensing and International Journal of Cancer.

In The Last Decade

Muxing Li

24 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muxing Li China 12 414 223 180 157 140 25 744
Akin Inderson Netherlands 15 215 0.5× 220 1.0× 110 0.6× 160 1.0× 202 1.4× 46 637
Junji Kita Japan 15 330 0.8× 293 1.3× 126 0.7× 134 0.9× 221 1.6× 37 663
Naohisa Kuriyama Japan 18 437 1.1× 559 2.5× 114 0.6× 278 1.8× 301 2.1× 117 1.0k
Hitoshi Kameyama Japan 18 351 0.8× 352 1.6× 138 0.8× 111 0.7× 101 0.7× 116 984
Tim A. Justin United Kingdom 7 807 1.9× 344 1.5× 201 1.1× 168 1.1× 70 0.5× 11 1.1k
Nesrin Turhan Türkiye 15 156 0.4× 241 1.1× 64 0.4× 118 0.8× 72 0.5× 70 694
Giacomo Borgonovo Italy 19 263 0.6× 527 2.4× 120 0.7× 212 1.4× 285 2.0× 62 1.1k
Keita Sakamoto Japan 16 171 0.4× 132 0.6× 147 0.8× 110 0.7× 75 0.5× 49 773
Ilias P. Gomatos Greece 15 332 0.8× 500 2.2× 73 0.4× 85 0.5× 58 0.4× 44 791
Akihiro Tanemura Japan 15 360 0.9× 437 2.0× 70 0.4× 170 1.1× 203 1.4× 101 723

Countries citing papers authored by Muxing Li

Since Specialization
Citations

This map shows the geographic impact of Muxing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muxing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muxing Li more than expected).

Fields of papers citing papers by Muxing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muxing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muxing Li. The network helps show where Muxing Li may publish in the future.

Co-authorship network of co-authors of Muxing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Muxing Li. A scholar is included among the top collaborators of Muxing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muxing Li. Muxing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shu, Chang, Cheng Zeng, Haiyang Li, et al.. (2023). Small-molecule exhibits anti-tumor activity by targeting the RNA m6A reader IGF2BP3 in ovarian cancer.. PubMed. 13(10). 4888–4902. 4 indexed citations
2.
Lu, Ming, Leyuan Fang, Muxing Li, et al.. (2022). NFANet: A Novel Method for Weakly Supervised Water Extraction From High-Resolution Remote-Sensing Imagery. IEEE Transactions on Geoscience and Remote Sensing. 60. 1–14. 36 indexed citations
3.
Fang, Leyuan, Jiahuan Guo, Xingxin He, & Muxing Li. (2022). Self-supervised patient-specific features learning for OCT image classification. Medical & Biological Engineering & Computing. 60(10). 2851–2863. 5 indexed citations
4.
Li, Muxing, Alexandra G. Lopez‐Aguiar, George A. Poultsides, et al.. (2022). Surgical Treatment of Neuroendocrine Tumors of the Terminal Ileum or Cecum: Ileocecectomy Versus Right Hemicolectomy. Journal of Gastrointestinal Surgery. 26(6). 1266–1274. 8 indexed citations
5.
Li, Muxing, Alexandra G. Lopez‐Aguiar, George A. Poultsides, et al.. (2022). Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma. Journal of Surgical Oncology. 126(4). 689–697. 6 indexed citations
6.
Li, Muxing, Hangyan Wang, Chunhui Yuan, et al.. (2021). Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Frontiers in Oncology. 11. 619517–619517. 15 indexed citations
7.
Li, Muxing, Hangyan Wang, Chunhui Yuan, et al.. (2021). Shark mouth pancreaticojejunostomy reduced the rate of clinically related pancreatic fistula: a historic cohort comparative analysis. HPB. 24(5). 727–736. 1 indexed citations
10.
Xiu, Dianrong, Hangyan Wang, & Muxing Li. (2019). The Research of drainage Trypsin Activation Peptide (TAP) in Post-Operation Pancreatic Fistula(POPF). HPB. 21. S446–S446. 1 indexed citations
11.
Wang, Hangyan, Muxing Li, & Dianrong Xiu. (2019). Shark mouth pancreaticojejunostomy. Chinese Medical Journal. 132(11). 1354–1358. 4 indexed citations
12.
Li, Zhiyu, Xiaolong Wu, Xinyu Bi, et al.. (2018). Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma. Chinese Journal of Cancer Research. 30(3). 364–372. 28 indexed citations
13.
Wang, Yikai, Xinyu Bi, Zhiyu Li, et al.. (2017). [A new prognostic score system of hepatocellular carcinoma following hepatectomy].. PubMed. 39(12). 903–909. 8 indexed citations
14.
Bi, Xinyu, Zhen Huang, Zhiyu Li, et al.. (2016). CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET. Medicine. 95(18). e3567–e3567. 6 indexed citations
15.
Cheng, Jiwen, Wanli Wang, Xi Liu, et al.. (2014). Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis. PLoS ONE. 9(1). e87011–e87011. 58 indexed citations
16.
Wang, Wanli, Ying Zhu, Jiwen Cheng, et al.. (2014). Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis. European Journal of Gastroenterology & Hepatology. 26(4). 444–451. 23 indexed citations
17.
Cheng, Jiwen, et al.. (2013). Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 48(9). 806–814. 27 indexed citations
18.
Zhang, Xu‐Feng, Xuemin Liu, Tao Wei, et al.. (2013). Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents. Pediatric Surgery International. 29(8). 763–770. 19 indexed citations
19.
Li, Muxing, Xu‐Feng Zhang, Zhengwen Liu, & Yi Lv. (2013). Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary & pancreatic diseases international. 12(5). 512–519. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026